BU Burcon NutraScience

Acquisition of Shares by Substantial Shareholder of Burcon NutraScience Corporation

Hong Kong, Hong Kong--(Newsfile Corp. - January 14, 2019) - Mr. Chan Yiu Lun, Alan ("Mr. Chan"), a director of Burcon NutraScience Corporation ("Burcon"), announces that on January 14, 2019, Mr. Chan, through his indirect wholly-owned company, Large Scale Investments Limited ("Large Scale"), a company incorporated in the British Virgin Islands whose registered office is situate at Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands, entered into a private agreement for sale and purchase with Dr. Allan Yap ("Dr. Yap") to acquire from Dr. Yap 1,566,719 common shares (the "Sale Shares") in the capital of Burcon at a total consideration of HK$1,843,000 (approximately C$311,792 based on the exchange rate of C$1 = HK$5.911) (the "Acquisition"). Transfer of the Sale Shares to Large Scale was to take place on January 14, 2019 after signing of the agreement.

Before the Acquisition,

(a) Mr. Chan, through his indirect wholly-owned companies, Large Scale and Great Intelligence Limited (“Great Intelligence”), was deemed to beneficially own (i) 9,866,568 common shares (the "Pre-Acquisition Shares") in the capital of Burcon, amongst which 7,225,510 common shares are held by Large Scale and 2,641,058 common shares are held by Great Intelligence; and (ii) the convertible unsecured 8% promissory note in the principal amount of C$2,000,000 (the “Note”) held by Large Scale, which is convertible into 507,614 Burcon common shares at a price of C$3.94 per share (subject to adjustments) during the period commencing on or after July 1, 2016 and up to and including the maturity date, which is the earlier of (a) three years from the issue of the Note; and (b) the occurrence of an event of default; and
   
(b) Mr. Chan does not hold any Burcon common shares but holds 210,844 options (the “Chan Options”) issued by Burcon, which are exercisable by Mr. Chan to purchase Burcon common shares at various exercise prices ranging from C$0.69 to C$8.65 per share.
   

As a result of the Acquisition, the number of Burcon shares held by Large Scale increased from 7,225,510 to 8,792,229. Since Mr. Chan was deemed to control Large Scale and Great Intelligence, he was also deemed to beneficially own the Sale Shares, the Pre-Acquisition Shares and the Note. The total number of Burcon shares held by Large Scale and Great Intelligence, which Mr. Chan was deemed to beneficially own, increased from 9,866,568 (22.45%) to 11,433,287 (26.02%) (the "Post-Acquisition Shares"). The afore-mentioned percentage is calculated based on 43,941,536 issued and outstanding common shares of Burcon as of January 14, 2019.

If Mr. Chan and Large Scale were to exercise all of the Chan Options and the Note, Mr. Chan may then be deemed to beneficially own 12,151,745 Burcon common shares (including the 11,433,287 Post-Acquisition Shares), representing approximately 27.21% of the issued and outstanding Burcon Shares as at January 14, 2019, assuming all the Chan Options and the Note are exercised/converted but that no other convertible securities of Burcon are exercised.

It is intended that the Sale Shares acquired by Large Scale will be held for investment purposes. Mr. Chan may, depending on market and other conditions, increase or decrease his beneficial ownership of Burcon's securities, whether in the open market, by privately negotiated agreements or otherwise, subject to a number of factors, including general market conditions and other available investment and business opportunities.

For further information, or to obtain a copy of the subject early warning report filed by Mr. Chan in accordance with applicable Canadian securities laws, please contact the director of Large Scale at (852) 2831 8118.

"Chan Yiu Lun, Alan"
________________
Chan Yiu Lun, Alan

Date : January 14, 2019

"Rosanna Chau"
________________
Rosanna Chau for and on behalf of
Large Scale Investments Limited

Date : January 14, 2019

EN
14/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Burcon NutraScience

 PRESS RELEASE

Burcon to Showcase High Purity Plant Proteins at 2025 IFT FIRST Annual...

Attendees are invited to visit Burcon at booth S4066 to explore its unique plant protein solutionsVancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce its participation in this year's Institute of Food Technologists Annual Meeting and Exposition ("IFT FIRST") in Chicago, IL, from July 13-16 in exhibit booth S4066.Burcon will showcase its full suite of best-in-class plant-based protein ingredients, all of which have...

 PRESS RELEASE

Burcon Achieves First Commercial Production of Pea Protein

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the successful first commercial production run of its next-generation Peazazz®C pea protein at its Galesburg facility in Illinois, USA."The successful startup of our Galesburg facility marks a key operational milestone in Burcon's commercial scale-up," said Kip Underwood, Burcon's chief executive officer. "In less than 90 days since commissioning, our team has bro...

 PRESS RELEASE

Burcon to Participate in 2025 Canadian Climate Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has been invited to present and participate on a panel discussion at the 2025 Canadian Climate Investor Conference ("CCIC"), taking place on Wednesday June 11, 2025 at the Arcadian Court in Toronto, Ontario."As a pure-play plant protein innovation company based in Canada, we're excited to participate in a purpose-driven inv...

 PRESS RELEASE

Burcon Integrates Protein Technologies at Galesburg Facility

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has successfully installed and commissioned equipment for its proprietary process at the Galesburg facility."In just 10 days, our team-working alongside our valued partner RE ProMan LLC-successfully installed and commissioned our proprietary unit processes at the Galesburg facility," said Kip Underwood, Burcon's chief exec...

 PRESS RELEASE

Burcon Announces its Alliance Partner Completes Acquisition of Protein...

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, proudly announces that its alliance partner, RE ProMan, LLC ("ProMan"), has successfully completed the acquisition of a protein production facility located in Galesburg, Illinois (the "Transaction")."We are thrilled to complete this Transaction ahead of schedule and begin integrating Burcon's technologies into the facility," said John Vassallo, a Burco...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch